Know who buys
Most paid campaigns are built around who clicks. We build around who actually buys. That means fewer leads overall but a sales team that stops rejecting what marketing sends them.
We reply within 1 business day with a real diagnosis - not a calendar link, not a deck. 50+ B2B SaaS clients · 5.0 on Clutch.
PipeRocket runs marketing for digital health, EHR, telehealth, payer, and provider platforms. SEO, PPC, and pipeline ops built around clinical buying committees, HIPAA / BAA gating, peer-evidence positioning, and the 12–18 month pilot cycles that come with patient data and clinical workflows.
Healthtech buyers demand HIPAA compliance before a demo and peer-reviewed evidence before a signature. We build programmes that surface both early and convert clinical buying committees into qualified pipeline.
Most paid campaigns are built around who clicks. We build around who actually buys. That means fewer leads overall but a sales team that stops rejecting what marketing sends them.
Ads are written around real clinical buying moments and real compliance concerns, pulled from actual sales call recordings. Generic feature lists and buzzwords fill dashboards. They do not fill pipelines.
Lead quality is validated through actual sales conversations and acceptance rates, not marketing dashboards. When sales reject a lead, we want to know why and fix the upstream cause.
We put spend behind clinical and IT buyers already evaluating solutions, not cold audiences that need months of nurturing before they are ready to talk to sales. Budget follows intent, not reach.
You can see exactly what is influencing the pipeline and where leads drop off, not just what happened at the click. Every touchpoint is connected to revenue so the board question has a clear answer.
Budgets follow performance. When something consistently drives the pipeline we scale it. When it does not we pause it and find out why. No spend exists to show activity.
Every agency promises growth. The gap is whether they can navigate HIPAA review, clinical buying committees, and a multi-quarter pilot without losing the deal.
Most healthtech agencies still run their playbook manually. We built our delivery around AI agents. HIPAA-aware content briefs, peer-evidence framing, clinical-outcome messaging, audit refreshes, and provider-cycle attribution, so what used to take a quarter ships every sprint, and senior strategists stay senior.
AI agents own the data layer, audience builds, ad variants, bid optimisation, attribution. Senior paid strategists own every campaign call when the buyer is a clinical or compliance leader and the wrong claim triggers a HIPAA review.
Our agents complete entire paid workflows end to end: healthcare-buyer audience research, ad copy generation, landing-page hypotheses, bid signals, attribution. Not a "smart suggestion" button next to a media planner's checklist. Autonomous agents that finish the task and hand it to a strategist for the call.
Agents watch every campaign across Google Ads, LinkedIn, and programmatic channels in real time. Audience fatigue, bid-signal shifts, creative decay, and budget waste get flagged the moment they appear, not at the Monday standup three days after spend was burned chasing low-intent healthcare clicks.
Agents handle the execution layer: audience builds, variant generation, in-platform optimisation, attribution. Senior strategists own the calls that move spend, which provider, payer, and clinical-buyer segments to scale, which tests to back, and the review every outcome or compliance claim a regulated health category demands.
Every agent reports to one number: pipeline-tied ROAS. CPC, CTR, and impression share are diagnostic, never the goal. CAC, payback period, and pipeline contribution by channel surface continuously so the healthtech-spend story holds up in the boardroom.
We focus on outcomes, not activity. Each phase builds on the last, and we know that after the fundamentals are priced.
We start by understanding your product, your market, and the real problem you solve. This includes getting clarity on your ICP, buying triggers, and business goals.
We align on what success looks like, set clear sales and marketing expectations, map the full funnel, and put proper tracking in place. The goal is simple: everyone agrees on who you’re targeting, why they buy, and how results will be measured.
We start by understanding your product, your market, and the real problem you solve. This includes getting clarity on your ICP, buying triggers, and business goals.
We align on what success looks like, set clear sales and marketing expectations, map the full funnel, and put proper tracking in place. The goal is simple: everyone agrees on who you’re targeting, why they buy, and how results will be measured.
With clarity in place, we turn insights into a focused plan. We validate offers and messaging, define a testing framework, forecast pipeline and budget pacing, and build a clear 30-60-90 day roadmap.
We also define the creative direction and assets needed so execution doesn’t stall later. This phase removes guesswork before a single dollar is scaled.
We launch with speed and intention. Campaigns go live on Google and LinkedIn with clean structure, precise targeting, and clear goals.
Early traffic and audience signals are closely monitored to understand intent and quality from the start. This phase is about learning fast without sacrificing discipline.
Optimization goes beyond ads and bids. We regularly review performance against benchmarks, improve targeting and messaging, assess lead quality, and connect campaign data to product usage and sales conversations.
Weekly reviews keep execution tight, while monthly reviews ensure strategy stays aligned with pipeline and revenue outcomes.
We scale only after proof. Once the system consistently produces qualified pipeline, we increase budgets, expand into new segments or regions, and deepen creative and experimentation.
Growth happens in a controlled way, without burning budget or credibility.






Each agent owns one stage of how a paid dollar becomes a meeting, audience, creative, landing page, bid, attribution. They run continuously and feed every decision to the senior paid strategist on the account.
Scans intent signals, firmographic data, and buyer behaviour across Google, LinkedIn, and third-party sources to surface providers, payers, and clinical and compliance leaders actually in-market for your healthtech product. Builds that took two weeks now ship in 48 hours.
Generates 30+ ad variants per audience from your sales-call transcripts and competitor angles, flagging clinical outcome and HIPAA claims that need compliance review, ready to test in days instead of months.
Produces landing-page hypotheses tied to each ad audience so the on-page experience matches click-through intent. The CTA, proof points, and MQL path are decided before healthcare buyers land.
Monitors campaigns continuously, flagging underperforming ad sets, audience fatigue, budget inefficiencies, and bid-signal shifts before they become pipeline problems. What to pause or scale stays with the team.
Connects every paid touchpoint to your CRM, surfacing CAC, payback period, and pipeline influenced by channel, audience, and creative across long healthcare sales cycles. The reporting your board wants, generated continuously.
Pipeline-led growth for HyperVerge. KYC / identity verification, adjacent to healthtech buyers managing patient identity and data integrity.
Read full story
Compliance-led growth for CyberSierra, directly relevant for healthtech vendors selling into HIPAA, HITRUST, and SOC 2 reviews.
Read full storyAchieving 127% Organic Traffic Growth in 6 Months: DevRev's Case Study with PipeRocket.
Read full storyBetter tools do not produce better SEO. Better judgment does. We happen to have both.
We work with a small number of healthtech B2B SaaS companies at a time. If your pipeline isn’t growing the way your board expects, let’s find out if we’re the right fit.
Book free consultation